Big Pharma’s Lawuits

In the last few years pharmaceutical companies have agreed to pay over $13 billion to resolve U.S. Department of Justice allegations of fraudulent marketing practices, including the promotion of medicines for uses that were not approved by the Food and Drug Administration. Here are summaries of some recent large settlements.

Full article

Related:

https://www.justice.gov/opa/pr/johnson-johnson-pay-more-22-billion-resolve-criminal-and-civil-investigations

https://www.ftc.gov/news-events/press-releases/1996/01/ftc-gives-final-approval-consent-agreement-johnson-johnson

https://www.nytimes.com/1995/04/11/business/ortho-fined-7.5-million-in-retin-a-case.html

https://www.nytimes.com/2001/04/18/business/johnson-johnson-settles-lawsuits-over-contact-lenses.html

https://www.justice.gov/opa/pr/two-johnson-johnson-subsidiaries-pay-over-81-million-resolve-allegations-label-promotion

https://www.forbes.com/sites/amywestervelt/2011/11/01/as-report-reveals-toxic-ingredients-in-baby-shampoo-johnson-johnson-goes-public-with-plans-to-clean-up-products/?sh=5f9a5a534b5a

https://www.forbes.com/sites/amywestervelt/2011/11/01/as-report-reveals-toxic-ingredients-in-baby-shampoo-johnson-johnson-goes-public-with-plans-to-clean-up-products/?sh=5f9a5a534b5a

https://www.reuters.com/investigates/special-report/johnsonandjohnson-cancer/

https://www.corp-research.org/jnj